Immunofluorescence analysis of SLC25A39 in parental and SLC25A39 knockout HeLa cells treated with BSO (1 mM) and erastin (5 uM) for 24 h (bottom)
This, in turn, boosts metabolic rate and activates a gene known as sirtuin-1 (SIRT1), also referred to as the "longevity gene." SIRT1 is involved in reducing the risk of various conditions such as diabetes, obesity, metabolic syndrome, atherosclerosis, cardiovascular disease, kidney disease, liver disease, neurodegeneration, and cancer.
Q: Is there a maximum recommended 5-Amino-1MQ dosage for research
Polymorphisms in the selenoprotein S gene and subclinical cardiovascular disease in the Diabetes Heart Study
In addition to muscles and tendons, BPC 157 also plays a role in joint and cartilage repair